(NASDAQ: ZURA) Zura Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Zura Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ZURA's revenue for 2028 to be $416,755,562, with the lowest ZURA revenue forecast at $416,755,562, and the highest ZURA revenue forecast at $416,755,562. On average, 1 Wall Street analysts forecast ZURA's revenue for 2029 to be $2,491,814,634, with the lowest ZURA revenue forecast at $2,491,814,634, and the highest ZURA revenue forecast at $2,491,814,634.
In 2030, ZURA is forecast to generate $14,108,657,948 in revenue, with the lowest revenue forecast at $14,108,657,948 and the highest revenue forecast at $14,108,657,948.